| Bioactivity | ChEs/MAOs-IN-2 (compound a11) is a cholinesterases and monoamine oxidases inhibitor with IC50 value of 0.10, 0.20, 0.30, 0.40 µM for MAO-A, MAO-B, AChE, and BChE, respectively. ChEs/MAOs-IN-2 has the potential for the research of Alzheimer's disease[1]. |
| CAS | 693268-77-8 |
| Formula | C15H12N2O3S |
| Molar Mass | 300.33 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jalil S, et al. Quinoline-sulfonamides as a multi-targeting neurotherapeutic for cognitive decline: in vitro, in silico studies and ADME evaluation of monoamine oxidases and cholinesterases inhibitors. RSC Adv. 2024 Mar 15;14(13):8905-8920. |
ChEs/MAOs-IN-2
CAS: 693268-77-8 F: C15H12N2O3S W: 300.33
ChEs/MAOs-IN-2 (compound a11) is a cholinesterases and monoamine oxidases inhibitor with IC50 value of 0.10, 0.20, 0.30,
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.